PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
Aggressive pharmacological intervention using statins, ezetimibe, or PCSK9 inhibitors.
WHAT DOES IT DO?
Virtually eliminates the mathematical probability of developing ASCVD by starving plaque formation.
HOW DO I USE IT?
Monitored via frequent bloodwork, operators titrate drugs to purposefully drive ApoB below 60 mg/dL.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
02Peter Attia
98.0